Francesco Ceci
Francesco Ceci
Division of Nuclear Medicine, Department of Medical Sciences, University of Turin
Verified email at unito.it - Homepage
Title
Cited by
Cited by
Year
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
WP Fendler, M Eiber, M Beheshti, J Bomanji, F Ceci, S Cho, F Giesel, ...
European journal of nuclear medicine and molecular imaging 44 (6), 1014-1024, 2017
2592017
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
F Ceci, C Uprimny, B Nilica, L Geraldo, D Kendler, A Kroiss, J Bektic, ...
European journal of nuclear medicine and molecular imaging 42 (8), 1284-1294, 2015
2152015
68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage …
J Calais, J Czernin, M Cao, AU Kishan, JV Hegde, N Shaverdian, ...
Journal of Nuclear Medicine 59 (2), 230-237, 2018
1092018
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?
P Castellucci, F Ceci, T Graziani, R Schiavina, E Brunocilla, R Mazzarotto, ...
Journal of Nuclear Medicine 55 (9), 1424-1429, 2014
1082014
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial
F Ceci, K Herrmann, P Castellucci, T Graziani, C Bluemel, R Schiavina, ...
European journal of nuclear medicine and molecular imaging 41 (12), 2222-2231, 2014
842014
11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT
F Ceci, P Castellucci, T Graziani, R Schiavina, E Brunocilla, R Mazzarotto, ...
European journal of nuclear medicine and molecular imaging 41 (5), 878-886, 2014
732014
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level< 0.5 ng/mL
M Mamede, F Ceci, P Castellucci, R Schiavina, C Fuccio, C Nanni, ...
Clinical nuclear medicine 38 (9), e342-e345, 2013
682013
11C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy
F Ceci, P Castellucci, M Mamede, R Schiavina, D Rubello, C Fuccio, ...
European journal of nuclear medicine and molecular imaging 40 (2), 149-155, 2013
602013
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
F Ceci, P Castellucci, T Graziani, R Schiavina, R Renzi, M Borghesi, ...
European journal of nuclear medicine and molecular imaging 43 (1), 84-91, 2016
552016
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series
T Graziani, F Ceci, P Castellucci, G Polverari, GM Lima, F Lodi, ...
European journal of nuclear medicine and molecular imaging 43 (11), 1971-1979, 2016
542016
Comparison of 68Ga-PSMA-11 and 18F-fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
J Calais, WP Fendler, K Herrmann, M Eiber, F Ceci
Journal of Nuclear Medicine 59 (5), 789-794, 2018
522018
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging …
J Calais, F Ceci, M Eiber, TA Hope, MS Hofman, C Rischpler, ...
The Lancet Oncology 20 (9), 1286-1294, 2019
512019
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
S Fanti, S Minozzi, JJ Morigi, F Giesel, F Ceci, C Uprimny, MS Hofman, ...
European journal of nuclear medicine and molecular imaging 44 (10), 1622-1635, 2017
412017
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment …
A Farolfi, F Ceci, P Castellucci, T Graziani, G Siepe, A Lambertini, ...
European journal of nuclear medicine and molecular imaging 46 (1), 11-19, 2019
382019
11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer
F Ceci, P Castellucci, T Graziani, R Schiavina, S Chondrogiannis, ...
Clinical nuclear medicine 40 (5), e265-e270, 2015
352015
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy
F Ceci, P Castellucci, T Graziani, A Farolfi, C Fonti, F Lodi, S Fanti
European journal of nuclear medicine and molecular imaging 46 (1), 31-39, 2019
292019
Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings
E Brunocilla, F Ceci, R Schiavina, P Castellucci, AM Maffione, M Cevenini, ...
Clinical nuclear medicine 39 (5), e308-e312, 2014
282014
Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings
E Brunocilla, F Ceci, R Schiavina, P Castellucci, AM Maffione, M Cevenini, ...
Clinical nuclear medicine 39 (5), e308-e312, 2014
282014
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques
R Schiavina, F Ceci, M Borghesi, E Brunocilla, V Vagnoni, M Gacci, ...
Curr Radiopharm 6 (2), 92-5, 2013
282013
Restaging clear cell renal carcinoma with 18F-FDG PET/CT
C Fuccio, F Ceci, P Castellucci, EG Spinapolice, R Palumbo, ...
Clinical nuclear medicine 39 (6), e320-e324, 2014
262014
The system can't perform the operation now. Try again later.
Articles 1–20